002788SZSE

2025 Annual Report

Luyan Pharmaceutical Co., Ltd.··178p

✨ AI Summary

Luyan Pharmaceutical Co., Ltd. released its 2025 Annual Report, detailing its financial performance and business operations. The company reported operating income of CNY 21.25 billion, a 3.79% increase year-on-year. However, net profit decreased by 18.74% to CNY 280.88 million. The report highlights a focus on medical devices, which constitute 90.98% of revenue, and outlines strategies for market expansion and operational efficiency amidst potential risks.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openaiSign In to Upgrade

2025 Annual Report

Important Notice, Table of Contents, and Explanation

The company's board of directors and senior management guarantee the truthfulness, accuracy, and completeness of the contents of the annual report, and are responsible for any false records, misleading statements, or significant omissions, and undertake legal responsibilities.

The person in charge of the company is Wu Jinxiang, the chief accountant is responsible for the accounting work, and the accounting personnel are responsible for the financial statements. The board of directors confirms that the annual report is true, accurate, and complete.

All directors have attended the board meeting to review this report.

This report and the future plans are subject to risks related to investment. Please pay attention to investment risks.

The company has detailed possible related risks in this report, and the management discusses the company's operational risks and corresponding mitigation measures in Section 3.

The board of directors has approved the profit distribution proposal: based on the total shares of 388, 516, and 736, a cash dividend of CNY 3.50 (tax included) will be distributed for every 10 shares, with no bonus shares (tax excluded), and no increase in the company's registered capital.

Table of Contents

  1. Important Notice, Table of Contents, and Explanation .......................................................... 2
  2. Overview of the Company and Main Business ................................................................. 6
  3. Management Discussion and Analysis .................................................................... 10
  4. Corporate Governance, Environmental and Social Responsibility .......................... 27
  5. Important Events ........................................................................................................ 40
  6. Share Capital Changes and Market Conditions ......................................................... 67
  7. Related Party Transactions ...................................................................................... 73
  8. Financial Statements ................................................................................................. 74

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Notes & Comments

Sign in to leave a comment or private note.

Loading…